Hot Pursuit     27-Jun-23
Zydus Lifesciences Ltd rises for third consecutive session
Zydus Lifesciences Ltd is quoting at Rs 570.75, up 1.59% on the day as on 12:49 IST on the NSE. The stock is up 59.54% in last one year as compared to a 18.23% jump in NIFTY and a 10.09% jump in the Nifty Metal index.

Zydus Lifesciences Ltd is up for a third straight session today. The stock is quoting at Rs 570.75, up 1.59% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.26% on the day, quoting at 18739.5. The Sensex is at 63135.64, up 0.26%. Zydus Lifesciences Ltd has gained around 11.46% in last one month.

Meanwhile, Nifty Metal index of which Zydus Lifesciences Ltd is a constituent, has gained around 6.51% in last one month and is currently quoting at 13388.6, up 0.43% on the day. The volume in the stock stood at 6.08 lakh shares today, compared to the daily average of 11.07 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 570.35, up 1.44% on the day. Zydus Lifesciences Ltd is up 59.54% in last one year as compared to a 18.23% jump in NIFTY and a 10.09% jump in the Nifty Metal index.

The PE of the stock is 33.81 based on TTM earnings ending March 23.

Previous News
  Zydus receives Mexican regulatory approval for cancer drug - Bhava™
 ( Corporate News - 22-Jul-24   09:09 )
  Zydus Life gets final approval from USFDA for cancer drug
 ( Hot Pursuit - 28-Sep-24   14:42 )
  Zydus Lifesciences Ltd spurts 0.43%, up for five straight sessions
 ( Hot Pursuit - 08-Jul-24   13:01 )
  Zydus receives USFDA approval for Enzalutamide capsules
 ( Corporate News - 28-Sep-24   14:21 )
  Indices trade higher; consumer durable shares rally
 ( Market Commentary - Mid-Session 22-Apr-24   13:37 )
  Zydus and Daewoong sign exclusive licensing agreement
 ( Corporate News - 11-Dec-23   10:24 )
  Zydus Life edges higher after launching OAB treatment drug Mirabegron in US
 ( Hot Pursuit - 22-Apr-24   09:25 )
  Zydus Life arm inks pact with Daewoong Pharma to market Leuprolide Acetate
 ( Hot Pursuit - 11-Dec-23   11:22 )
  Zydus Lifesciences consolidated net profit rises 30.64% in the June 2024 quarter
 ( Results - Announcements 09-Aug-24   13:48 )
  Zydus Lifesciences receives USFDA approval for Icosapent Ethyl Capsules
 ( Corporate News - 24-Apr-23   08:56 )
  Zydus Life gets USFDA final nod for antilipemic
 ( Hot Pursuit - 24-Apr-23   08:58 )
Other Stories
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
  Volumes soar at Avenue Supermarts Ltd counter
  04-Oct-24   14:30
Back Top